Interestingly, the presence of nasal polyps in one of nine patients belonging to the IL-5-negative Cluster-1 demonstrates that the CRSwNP phenotype is not always associated with type-2 endotype, which is of clinical importance when planning biologic therapies. Here, IL5 is linked to nasal cavity polyp.